News on Palo Alto Research Center from BioPortfolio.com http://www.BioPortfolio.com Consolidated Palo Alto Research Center news from BioPortfolio.com Wed, 10 Feb 2010 04:40:27 GMT en Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034857&HITNO=0&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034857&THISHREF=http://c.moreover.com/click/here.pl%3fz2536015272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034857&HITNO=0&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034857&THISHREF=http://c.moreover.com/click/here.pl%3fz2536015272%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHealthcare Sales & Marketing Network: Power times twohttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=1&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032789&HITNO=1&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032789&THISHREF=http://c.moreover.com/click/here.pl%3fz2534822731%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comDrug Discovery News: Ozmo Devices Announces New CEO Bill McLean to Take Reins of Wi-Fi PAN Market Leaderhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035408&HITNO=2&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035408&THISHREF=http://c.moreover.com/click/here.pl%3fz2536229282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035408&HITNO=2&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035408&THISHREF=http://c.moreover.com/click/here.pl%3fz2536229282%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Cardiovascular NursesEUR Actions Speak Louder Than Wordshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031591&HITNO=3&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031591&THISHREF=http://c.moreover.com/click/here.pl%3fz2534272721%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4031591&HITNO=3&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4031591&THISHREF=http://c.moreover.com/click/here.pl%3fz2534272721%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNurse.com: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028974&HITNO=4&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028974&THISHREF=http://c.moreover.com/click/here.pl%3fz2532936970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028974&HITNO=4&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028974&THISHREF=http://c.moreover.com/click/here.pl%3fz2532936970%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: Neuraltus Pharmaceuticals Names Andrew Gengos President and CEOhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028914&HITNO=5&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028914&THISHREF=http://c.moreover.com/click/here.pl%3fz2532900325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028914&HITNO=5&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028914&THISHREF=http://c.moreover.com/click/here.pl%3fz2532900325%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028277&HITNO=6&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028277&THISHREF=http://c.moreover.com/click/here.pl%3fz2532658553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4028277&HITNO=6&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4028277&THISHREF=http://c.moreover.com/click/here.pl%3fz2532658553%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPortland Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027877&HITNO=7&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027877&THISHREF=http://c.moreover.com/click/here.pl%3fz2532433633%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027877&HITNO=7&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027877&THISHREF=http://c.moreover.com/click/here.pl%3fz2532433633%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comCincinnati Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027822&HITNO=8&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027822&THISHREF=http://c.moreover.com/click/here.pl%3fz2532378923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027822&HITNO=8&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027822&THISHREF=http://c.moreover.com/click/here.pl%3fz2532378923%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comColumbus Business First: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027754&HITNO=9&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027754&THISHREF=http://c.moreover.com/click/here.pl%3fz2532324075%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027754&HITNO=9&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027754&THISHREF=http://c.moreover.com/click/here.pl%3fz2532324075%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027701&HITNO=10&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027701&THISHREF=http://c.moreover.com/click/here.pl%3fz2532299659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027701&HITNO=10&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027701&THISHREF=http://c.moreover.com/click/here.pl%3fz2532299659%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comHouston Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027699&HITNO=11&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027699&THISHREF=http://c.moreover.com/click/here.pl%3fz2532296243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027699&HITNO=11&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027699&THISHREF=http://c.moreover.com/click/here.pl%3fz2532296243%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSouth Florida Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027681&HITNO=12&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027681&THISHREF=http://c.moreover.com/click/here.pl%3fz2532292148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027681&HITNO=12&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027681&THISHREF=http://c.moreover.com/click/here.pl%3fz2532292148%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNashville Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027678&HITNO=13&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027678&THISHREF=http://c.moreover.com/click/here.pl%3fz2532291809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027678&HITNO=13&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027678&THISHREF=http://c.moreover.com/click/here.pl%3fz2532291809%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBoston Business Journal: Silence Therapeutics Receives Notice of Allowance for RNA Interference (RNAi) Patent Covering Novel Cancer Targethttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027671&HITNO=14&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027671&THISHREF=http://c.moreover.com/click/here.pl%3fz2532289485%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4027671&HITNO=14&MSIZE=319&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Palo%20Alto%20Research%20Center&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4027671&THISHREF=http://c.moreover.com/click/here.pl%3fz2532289485%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: